FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897827524> ?p ?o ?g. }

• W2897827524 endingPage "e0204513" @default.
• W2897827524 startingPage "e0204513" @default.
• W2897827524 abstract "In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2, mesenchymal (M), and luminal androgen receptor (LAR)], and an immunomodulatory (IM) gene expression signature indicates the presence of TILs and modifies these subtypes. The association between TNBC subtype and TILs is not known. Also, the association between inflammatory breast cancer (IBC) and the presence of TILs is not known. Therefore, we studied the IM subtype distribution among different TNBC subtypes. We retrospectively analyzed patients with TNBC from the World IBC Consortium dataset. The molecular subtype and the IM signature [positive (IM+) or negative (IM-)] were analyzed. Fisher's exact test was used to analyze the distribution of positivity for the IM signature according to the TNBC molecular subtype and IBC status. There were 88 patients with TNBC in the dataset, and among them 39 patients (44%) had IBC and 49 (56%) had non-IBC. The frequency of IM+ cases differed by TNBC subtype (p = 0.001). The frequency of IM+ cases by subtype was as follows: BL1, 48% (14/29); BL2, 30% (3/10); LAR, 18% (3/17); and M, 0% (0/21) (in 11 patients, the subtype could not be determined). The frequency of IM+ cases did not differ between patients with IBC and non-IBC (23% and 33%, respectively; p = 0.35). In conclusion, the IM signature representing the underlying molecular correlate of TILs in the tumor may differ by TNBC subtype but not by IBC status." @default.
• W2897827524 created "2018-10-26" @default.
• W2897827524 creator A5000514150 @default.
• W2897827524 creator A5006599402 @default.
• W2897827524 creator A5016731809 @default.
• W2897827524 creator A5024773591 @default.
• W2897827524 creator A5027464426 @default.
• W2897827524 creator A5028987280 @default.
• W2897827524 creator A5033135467 @default.
• W2897827524 creator A5039325608 @default.
• W2897827524 creator A5040423978 @default.
• W2897827524 creator A5047800296 @default.
• W2897827524 creator A5053893309 @default.
• W2897827524 creator A5075717157 @default.
• W2897827524 creator A5077531941 @default.
• W2897827524 creator A5082923675 @default.
• W2897827524 creator A5088814426 @default.
• W2897827524 creator A5090262146 @default.
• W2897827524 creator A5091721810 @default.
• W2897827524 date "2018-10-12" @default.
• W2897827524 modified "2023-10-16" @default.
• W2897827524 title "Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype" @default.
• W2897827524 cites W183114306 @default.
• W2897827524 cites W1989938935 @default.
• W2897827524 cites W2046016820 @default.
• W2897827524 cites W2053662475 @default.
• W2897827524 cites W2098683355 @default.
• W2897827524 cites W2105504936 @default.
• W2897827524 cites W2112434826 @default.
• W2897827524 cites W2113334910 @default.
• W2897827524 cites W2118605519 @default.
• W2897827524 cites W2134539328 @default.
• W2897827524 cites W2134878729 @default.
• W2897827524 cites W2151408251 @default.
• W2897827524 cites W2155802897 @default.
• W2897827524 cites W2157058802 @default.
• W2897827524 cites W2159274850 @default.
• W2897827524 cites W2160928966 @default.
• W2897827524 cites W2170602872 @default.
• W2897827524 cites W2287133162 @default.
• W2897827524 cites W2430731787 @default.
• W2897827524 cites W2553558766 @default.
• W2897827524 cites W2560367415 @default.
• W2897827524 cites W2593709873 @default.
• W2897827524 cites W2605607341 @default.
• W2897827524 cites W2616669149 @default.
• W2897827524 doi "https://doi.org/10.1371/journal.pone.0204513" @default.
• W2897827524 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6193579" @default.
• W2897827524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30312311" @default.
• W2897827524 hasPublicationYear "2018" @default.
• W2897827524 type Work @default.
• W2897827524 sameAs 2897827524 @default.
• W2897827524 citedByCount "30" @default.
• W2897827524 countsByYear W28978275242019 @default.
• W2897827524 countsByYear W28978275242020 @default.
• W2897827524 countsByYear W28978275242021 @default.
• W2897827524 countsByYear W28978275242022 @default.
• W2897827524 countsByYear W28978275242023 @default.
• W2897827524 crossrefType "journal-article" @default.
• W2897827524 hasAuthorship W2897827524A5000514150 @default.
• W2897827524 hasAuthorship W2897827524A5006599402 @default.
• W2897827524 hasAuthorship W2897827524A5016731809 @default.
• W2897827524 hasAuthorship W2897827524A5024773591 @default.
• W2897827524 hasAuthorship W2897827524A5027464426 @default.
• W2897827524 hasAuthorship W2897827524A5028987280 @default.
• W2897827524 hasAuthorship W2897827524A5033135467 @default.
• W2897827524 hasAuthorship W2897827524A5039325608 @default.
• W2897827524 hasAuthorship W2897827524A5040423978 @default.
• W2897827524 hasAuthorship W2897827524A5047800296 @default.
• W2897827524 hasAuthorship W2897827524A5053893309 @default.
• W2897827524 hasAuthorship W2897827524A5075717157 @default.
• W2897827524 hasAuthorship W2897827524A5077531941 @default.
• W2897827524 hasAuthorship W2897827524A5082923675 @default.
• W2897827524 hasAuthorship W2897827524A5088814426 @default.
• W2897827524 hasAuthorship W2897827524A5090262146 @default.
• W2897827524 hasAuthorship W2897827524A5091721810 @default.
• W2897827524 hasBestOaLocation W28978275241 @default.
• W2897827524 hasConcept C104317684 @default.
• W2897827524 hasConcept C121608353 @default.
• W2897827524 hasConcept C126322002 @default.
• W2897827524 hasConcept C143998085 @default.
• W2897827524 hasConcept C150194340 @default.
• W2897827524 hasConcept C191093355 @default.
• W2897827524 hasConcept C2777701055 @default.
• W2897827524 hasConcept C2778326572 @default.
• W2897827524 hasConcept C2779733811 @default.
• W2897827524 hasConcept C2780110267 @default.
• W2897827524 hasConcept C2780839634 @default.
• W2897827524 hasConcept C502942594 @default.
• W2897827524 hasConcept C530470458 @default.
• W2897827524 hasConcept C55493867 @default.
• W2897827524 hasConcept C71924100 @default.
• W2897827524 hasConcept C86803240 @default.
• W2897827524 hasConceptScore W2897827524C104317684 @default.
• W2897827524 hasConceptScore W2897827524C121608353 @default.
• W2897827524 hasConceptScore W2897827524C126322002 @default.
• W2897827524 hasConceptScore W2897827524C143998085 @default.
• W2897827524 hasConceptScore W2897827524C150194340 @default.

• next